Liver Diseases  >>  TG 4040  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TG 4040 / Transgene
HCVac, NCT01055821 / 2009-011121-13: Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

Completed
2
140
Europe
pegylated interferon and ribavirin, TG4040 + SOC
Transgene
Chronic Hepatitis C Infection
10/12
08/13

Download Options